2nd Quarter - Report

ARNOLD & PORTER KAYE SCHOLER LLP for RECORDATI RARE DISEASES INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Foreign entity interest: Recordati Rare Diseases Inc. is ultimately owned by Recordati Industria Chimica e Farmaceutica S.p.A., which may have an interest in the lobbying activity disclosed herein.

LobbyistCovered position, as disclosed
VICTORIA DAVILA —
PETER ERIC DUYSHART —
BOBBY MCMILLIN —
EUGENIA PIERSON —

Health Issues HCR

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Foreign entity interest: Recordati Rare Diseases Inc. is ultimately owned by Recordati Industria Chimica e Farmaceutica S.p.A., which may have an interest in the lobbying activity disclosed herein.

LobbyistCovered position, as disclosed
VICTORIA DAVILA —
PETER ERIC DUYSHART —
BOBBY MCMILLIN —
EUGENIA PIERSON —

Trade (domestic/foreign) TRD

Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.

Foreign entity interest: Recordati Rare Diseases Inc. is ultimately owned by Recordati Industria Chimica e Farmaceutica S.p.A., which may have an interest in the lobbying activity disclosed herein.

LobbyistCovered position, as disclosed
VICTORIA DAVILA —
PETER ERIC DUYSHART —
BOBBY MCMILLIN —
EUGENIA PIERSON —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.